Rising Biosciences (Rising Biosciences) EV-to-FCF : (As of Jun. 18, 2024)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Rising Biosciences's Enterprise Value is $0.00 Mil. Rising Biosciences does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Rising Biosciences's EV-to-FCF at this moment.

The historical rank and industry rank for Rising Biosciences's EV-to-FCF or its related term are showing as below:

RBII's EV-to-FCF is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 22.985
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-18), Rising Biosciences's stock price is $0.0001. Rising Biosciences does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Rising Biosciences's PE Ratio at this moment.

Rising Biosciences EV-to-FCF Historical Data

The historical data trend for Rising Biosciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences EV-to-FCF Chart

Rising Biosciences Annual Data

Trend

EV-to-FCF

Rising Biosciences Quarterly Data

EV-to-FCF

Competitive Comparison of Rising Biosciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's EV-to-FCF falls into.

Rising Biosciences EV-to-FCF Calculation

Rising Biosciences's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	0.000	/
	=

Rising Biosciences (GREY:RBII) EV-to-FCF Explanation

Rising Biosciences's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.0001	/
	=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Rising Biosciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » EV-to-FCF

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.